Stanley Hazen, MD, PhD, Cleveland Clinic Lerner Research Institute (IMAGE)

Cleveland Clinic

Stanley Hazen, MD, PhD, Cleveland Clinic Lerner Research Institute

Caption

Cleveland Clinic researchers, led by Stanley Hazen, MD, PhD, have identified a gut microbe generated byproduct - phenylacetylglutamine (PAG) -that is linked to development of cardiovascular disease, including heart attack, stroke and death.

Credit

Cleveland Clinic

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.